431 related articles for article (PubMed ID: 31420036)
1. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
[TBL] [Abstract][Full Text] [Related]
4. Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders.
Tunca Z; Kıvırcık Akdede B; Özerdem A; Alkın T; Polat S; Ceylan D; Bayın M; Cengizçetin Kocuk N; Şimşek S; Resmi H; Akan P
Eur Psychiatry; 2015 Feb; 30(2):198-204. PubMed ID: 25543333
[TBL] [Abstract][Full Text] [Related]
5. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
[TBL] [Abstract][Full Text] [Related]
6. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
[TBL] [Abstract][Full Text] [Related]
7. Serum nerve growth factor beta, brain- and glial-derived neurotrophic factor levels and psychopathology in unmedicated patients with schizophrenia.
Chu CS; Chu CL; Wu CC; Lu T
J Chin Med Assoc; 2018 Jun; 81(6):577-581. PubMed ID: 29366645
[TBL] [Abstract][Full Text] [Related]
8. Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Shimizu E; Hashimoto K; Iyo M
Neurosci Lett; 2014 Jul; 575():37-41. PubMed ID: 24861509
[TBL] [Abstract][Full Text] [Related]
9. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
[No Abstract] [Full Text] [Related]
12. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
[TBL] [Abstract][Full Text] [Related]
13. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
15. Serum BDNF levels, glycolipid metabolism in deficit schizophrenia: A case-control study.
Zhu X; Chen D; Xiu M; Li S; Zhang XY
Asian J Psychiatr; 2022 Mar; 69():103003. PubMed ID: 34999534
[TBL] [Abstract][Full Text] [Related]
16. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
17. Eye movement characteristics in male patients with deficit and non-deficit schizophrenia and their relationships with psychiatric symptoms and cognitive function.
Zhang L; Zhang X; Fang X; Zhou C; Wen L; Pan X; Zhang F; Chen J
BMC Neurosci; 2021 Nov; 22(1):70. PubMed ID: 34819034
[TBL] [Abstract][Full Text] [Related]
18. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
19. Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages.
He X; Song J; Gao H; Li Z; Wang X; Zeng Q; Xiao Y; Feng J; Zhou D; Wang G
Int J Psychiatry Clin Pract; 2023 Jun; 27(2):118-126. PubMed ID: 35980319
[TBL] [Abstract][Full Text] [Related]
20. A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia.
Niitsu T; Ishima T; Yoshida T; Hashimoto T; Matsuzawa D; Shirayama Y; Nakazato M; Shimizu E; Hashimoto K; Iyo M
Psychiatry Res; 2014 Feb; 215(2):268-73. PubMed ID: 24377440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
